Find Clinical Trials

Find Clinical Trials Interested in volunteering for research on Alzheimer’s disease, related dementias, and cognitive health? Learn about new and featured studies below or search for clinical trials and studies near you with the Alzheimers.gov Clinical Trials Finder. New and featured studies Click on the trial name for details and contact information. Caregiving Mindfulness Program To Reduce Depression in Dementia Caregivers (Saint Paul, MN) SilverBills: A Financial and Legal Tool for Dementia Caregivers (online) SoCal Savvy: Dementia Caregiver Education Program (Los Angeles, CA) Tele-STELLA: Online Family Caregiver Program To Reduce Distressing Dementia Behaviors (online) Drugs Safety and Effects of LY3372993 for Alzheimer's Disease (multiple locations) Trappsol Cyclo for Early-Stage Alzheimer's Disease (multiple locations) Valacyclovir for Mild Cognitive Impairment (New York, NY) Cognitive Training and Brain Stimulation Cognitive-Motor Training To Improve Mobility in Healthy Older Adults (Washington, D.C.) Non-Invasive Brain Stimulation To Improve Memory (Minneapolis, MN) Featured Registries and Matching Services Asian Cohort for Alzheimer's Disease (ACAD) — Sign up to join a study to identify risk factors associated with Alzheimer's in people of Asian ancestry. MindCrowd — Enroll to take a brief online cognition test and join a registry to be contacted about future research studies on the aging brain. Trial-Ready Cohort — Down Syndrome — Enroll to help improve methods for tracking Alzheimer’s disease progression in people with Down syndrome through cognitive and clinical testing, genetic and biomarker testing, brain imaging, and other tests. Get more information about these and other Alzheimer’s clinical trials online. Or, call the ADEAR Center at 800-438-4380 or email adear@nia.nih.gov.

Request for Proposals (RFP) on Clinical Site Monitoring and Data Management Services for The Biomarkers Consortium Kidney Safety Project

Request for Proposals (RFP) on Clinical Site Monitoring and Data Management Services for The Biomarkers Consortium Kidney Safety Project The National Institute of Mental Health is delighted to be a partner on the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ). The Foundation for the National Institutes of Health (NIH) is requesting information on Phase 2-ready compounds with a compelling biological hypothesis to address biological or clinical outcomes in the earliest stages of schizophrenia. This high-level overview is requested to inform on the selection of compounds for use in a biomarker focused proof of principle trial(s). The AMP SCZ project team looks forward to receiving your proposals and submissions by February 3, 2023!